Halozyme Therapeutic (HALO)
$59.35 -0.42 (-0.70%)| Market Cap | 7.88B |
| Revenue (ttm) | 1.02B |
| Net Income (ttm) | 444.09M |
| EPS (ttm) | N/A |
| PE Ratio | 15.78 |
| Forward PE | 13.06 |
| Profit Margin | 43.74% |
| Debt to Equity Ratio | 4.14 |
| Volume | 2,035,471 |
| Avg Vol | 1,339,240 |
| Day's Range | N/A - N/A |
| Shares Out | 123.53M |
| Stochastic %K | 35% |
| Beta | 1.32 |
| Analysts | Strong Sell |
| Price Target | $67.75 |
Latest News on HALO
No data available.